ASSOCIATION BETWEEN TOXOPLASMA GONDII INFECTION IN WOMEN AND THE PRESENCE OF CARDIOLIPIN AND PHOSPHOLIPID ANTIBODIES by N. A'aiz, Noaman et al.
European Scientific Journal  September 2014  /SPECIAL/ edition Vol.3   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
190 
ASSOCIATION BETWEEN TOXOPLASMA GONDII  
INFECTION IN WOMEN AND THE PRESENCE OF 
CARDIOLIPIN AND PHOSPHOLIPID ANTIBODIES 
 
 
 
Noaman N. A'aiz 
Dept. of Microbiology, College of Vet. Medicine , Univ. of Al-Qadissiya. 
Baqur A. Sultan 
Dept. of Microbiology, College of  Medicine, Univ. of Kufa.Iraq 
Sabah M. Al-Fatlawi 
Dept. of Clinical Immunology, Al-Sadar teaching hospital, Najaf. 
Abdulkareem A. Mahmood 
Dept of Community Medicine ,college of medicine ,Univ. of Kufa 
 
 
Abstract 
   IgG and IgM  cardiolipin  and  phospholipid  antibodies were measured, by an 
ELISA technique, in the sera of patients with toxoplasmosis. Immunological  methods for 
autoantibodies had been applied by ELISA. Regarding Anti-cardiolipin it was revealed that  
24.7%  of toxoplasmosis cases versus  0% of control group showed significant positive result 
(P=0.0412)  . Whereas, 12.5% of toxoplasmosis patients and 12% of healthy controls had 
anti-cardiolipin antibodies,  with no significant differences (P=0.554) between these two 
groups.  
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Introduction 
 There are several causes for  triggering  of autoimmune diseases and the infectious 
agents are one of these important causes (1).   The relationship between infections and 
autoimmune disease has been studied extensively over many years and described the 
association between microbiological infection (bacterial, viral and parasite) and development 
of autoimmunity (2, 16). The identification of microbial peptides that similar to self- tissue by 
molecular mimicry is a true factor that inducing or promoting autoimmune diseases triggering 
by certain infections (2).According to these association between the infectious agents and 
autoimmune triggering ,this study  suggests to identify if there is a correlation between T. 
gondii infection and autoimmune response throughout investigate the presence of anti-
cardiolipin  (aCL) and anti-phospholipid (aPL) ) antibodies,  in the sera of toxoplasmosis 
patients. 
 
Materials and methods 
 Fifty four  and thirty two sera of women were diagnosed with  toxoplasmosis were  
investigated for IgM and IgG anti-cardiolipin and anti-phospholipid antibodies tests 
respectively, in addition to 14 and 10 sera from healthy women as   control groups   randomly 
selected to compare the presence of  these antibodies respectively . All these sera were 
collected from women who  attended to the hospitals in AL-Najaf and AL-Qadissyha 
provinces in Iraq, from September 2008 to February 2009. 
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Results 
1-Anti- cardiolipin Antibody (aCL) 
 By ELISA, 13 (24.7%) of 54 toxoplasmosis cases showed positive anti-cardiolipin 
(concentration ≥ 7 u/ml), while no one (0%) of 14 healthy women showed positive result(P = 
0.0412)  (Table 1). 
Table (1): Anti-cardiolipin Seropositivity in Toxoplasmosis Cases and    Controls. 
 Anti-cardiolipin 
Groups No. 
Positive 
(≥ 7 u/ml) 
% 
Negative 
< 7u/ml 
% 
Toxoplasmosis cases 54 13 24.7 41 75.3 
controls 14 0 0 14 100 
X² = 4.17                             p= 0.0412 
 
2- Anti- Phospholipid  Antibody (aPL) 
 By ELISA, 4 (12.5%) of 32 toxoplasmosis cases showed positive aPL (concentration 
≥ 10 u/ml), versus  2 (20%) of 10 healthy women  (Table 2). 
Table (2): Anti- Phospholipid Seropositivity in Toxoplasmosis Cases and Controls 
 Anti- Phospholipid 
Groups No. 
Positive 
( ≥ 10 u/ml) 
% 
Negative 
(< 10u/ml) 
% 
Toxoplasmosis cases 32 4 12.5 28 87.5 
controls 10 2 20 8 80 
X² = 0.35               P= 0.554 
 
Discussion  
 Infection agent continues to be among the leading cause of morbidity and mortality 
worldwide. In addition, they are also implicated in the pathogenesis of  indirect consequences 
such as induction of the autoimmune diseases (7, 11, 12). 
 In the present study, two markers were examined to determine the autoimmune 
response in toxoplasmosis patients. 
 
1- Anti- Cardiolipin Antibody (aCL) 
 By ELISA, the study revealed that 13(24.7%) of 54 sera of toxoplasmosis patients 
showed positive aCL, while no one (0%) of 14 sera from healthy women showed positive 
aCL. There is significant difference (P<0.05) in the frequency of seropositive aCL between 
patients group and healthy control group. This result revealed a positive correlation between 
the disease and aCL. This result corresponding to the result of (10) in France and (1) in Italy, 
they recorded that, the levels of anticardiolipin (IgG & IgM) antibodies among those with 
toxoplasmosis were 29.3% and 27.4% respectively. 
 The explanation of this correlation is attributed firstly, to the mechanism of molecular 
mimicry, i.e. immunological cross-reactivity between the parasite and components of host 
tissues (8, 13), and secondly , Because aCL are strongly associated with recurrent pregnancy 
loss (3, 4); therefore, common abortions in patients with toxoplasmosis may be partially 
attributed to the presence of aCL. 
 In the present study there is no one (0%) of healthy control group had positive aCL 
and this result is disagreement with the finding of (9) who recorded that 10% of 100 healthy 
adults had positive aCL. This low aCL ratio in the current study may be due to the decrease 
number of tested healthy women. 
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2- Anti- Phospholipid (aPL) 
 The seropositivity of aPL antibodies were evaluated for 32 toxoplasmosis cases and 
10 healthy women by ELISA technique. Four (12.5%) toxoplasmosis cases and two (20%) 
healthy woman showed positive  aPL, but with no significant difference (P>0.05) between 
them. 
 This result is compatible with the result of (15); who showed that, the aPL antibodies 
in Leishmaniasis was revealed significant difference when compared with toxoplasmosis and 
malaria patients. While the current study is incompatible with (17); who estimated the 
prevalence of IgG and IgM antibodies to T. gondii in patients with antiphospholipid 
syndrome and found a significantly high prevalence of IgM antibodies only. But (5) 
confirmed that, the rising of IgM antibodies in antiphospholipid syndrome patient was false 
positive. 
 The difference in results of aPLseropositivity in toxoplasmosis patients may be 
attributed to genetic factors (6), environmental factors or presence of other co-infectious 
agents (14) and performance of  ELISA kit which used in each study .  
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